Vape Industry Trying to Lobby Federal, State Governments as “Essential Businesses”

Vaping is not an approved method of cessation- Surgeon General Vice Admiral Jerome Adams made that very clear during his 2020 Smoking Cessation report. Still, the industry is fighting at the state and federal level to stay open as an “essential business.”

The World Health Organization says smoking can increase your risk of catching COVID-19 and lead people who smoke to have more serious complications. Our friends at the Campaign for Tobacco Free Kids (CTFK) released this statement in response to the reports:

 

Absurd and Irresponsible: Vape Shops Claim They Are Essential When Vaping May Worsen Effects of COVID-19 and Has Addicted Millions of Kids

Statement of Matthew L. Myers, President, Campaign for Tobacco-Free Kids
April 15, 2020

WASHINGTON, D.C. – As we combat the coronavirus, it has never been more important to have healthy lungs. So it is absurd and irresponsible for vape shops to claim they are essential businesses that should be allowed to remain open during the COVID-19 shutdown. How in the world can vape shops make these claims when over 5 million kids use e-cigarettes and there is mounting concern among public health experts that smoking and vaping can worsen the effects of COVID-19? Vape shops should not be allowed to exploit a lung health crisis to push products that harm your lungs – especially products often sold in kid-friendly flavors like mint, gummy bear and cotton candy.

News reports indicate vape shops are lobbying the Trump Administration to be listed as essential, and they have similarly lobbied states and cities across the country. The Administration and other policy makers must reject these efforts. Now more than ever, our priority should be protecting the health and lungs of kids, not the special interests of vape shops.

The reasons to reject these vape shop appeals are clear.

The coronavirus attacks the lungs, and behaviors that weaken the lungs put individuals at greater risk. The harmful impact of smoking on the lungs is well documented, and there is growing evidence that vaping can harm lung health as well. Dr. Nora Volkow, Director of the National Institute on Drug Abuse, recently noted, “Because it attacks the lungs, the coronavirus that causes COVID-19 could be an especially serious threat to those who smoke tobacco or marijuana or who vape.” The Food and Drug Administration, which regulates e-cigarettes and other tobacco products, has publicly stated that people with underlying health conditions are particularly at risk, and this “includes people who smoke and/or vape tobacco or nicotine-containing products.”

Even before the COVID-19 crisis, e-cigarettes were addicting a new generation of kids and reversing decades of progress in reducing youth tobacco use. According to the 2019 National Youth Tobacco Survey, e-cigarette use among high school students nationwide increased to 27.5% in 2019 compared to 11.7% in 2017. Altogether, more than 5.3 million middle and high school students now use e-cigarettes.

While youth e-cigarette addiction has risen sharply, there is scant evidence that e-cigarettes benefit public health. Earlier this year, the U.S. Surgeon General issued a comprehensive report based on the best available evidence that found “there is presently inadequate evidence to conclude that e-cigarettes, in general, increase smoking cessation.”

It is highly irresponsible to argue that e-cigarettes should be considered essential when they could well put users at greater risk for serious complications from COVID-19, they are addicting our kids, and they have not been proven to help smokers quit. Rather than protecting vape shops, policy makers should act now to help more smokers and vapers quit and to prevent kids from ever starting to use tobacco products, including by prohibiting all flavored tobacco products. The coronavirus pandemic should serve as a wakeup call to make our lungs healthier now and for the future.

3 Students Win in the Big Tobacco Exposed Contest

Read more

CNN Health: Now’s the time to quit smoking: It could increase your odds of beating Covid-19

This article appeared on CNN Health’s webpage on April 3, 2020. The original link to the article can be found here.

Now’s the time to quit smoking: It could increase your odds of beating Covid-19

By Ryan Prior

(CNN)If you’ve been thinking about quitting smoking, there’s no time like the present pandemic.

With the novel coronavirus sweeping the globe, the science on quitting smoking offers welcome news for smokers who want to build up their defenses in case they contract Covid-19.
Though it may still take many months for a smoker’s lungs to heal from damage caused by long-term smoking, your health can noticeably improve in the days and weeks after quitting in ways that could make a difference against the virus.
Although you can’t reverse scarring to your lungs caused by smoking, there are a number of ways your lung health can improve in the short term, according to the US Centers for Disease Control and Prevention.

Time to strengthen your lungs

“Every lung doctor in America will be preaching that everyone should quit smoking.” Dr. Brian Christman, a volunteer spokesman with the American Lung Association and a professor of medicine at Vanderbilt University, told CNN. While this message isn’t new, it’s more relevant than ever.

Covid-19 creates an added sense of urgency, and there’s ample reason to believe that quitting smoking during the pandemic could increases your odds of fighting off the virus.
If you make the decision to quit, the cilia in your lungs are one of the first parts of your body to heal. These hair-like projections wave back and forth like a brush as air moves in and out of your lungs. They help your body fight off colds and infection, the CDC says. They also help clear mucus, so if they’re not functioning as well as they should, mucus can build up in the lungs.
Your body’s inclination to cough during an infection helps activate the bodily process of clearing out mucus, called the mucociliary escalator. That’s vital in fighting the Covid-19 condition.
The elderly are at a greater risk for excessive lung fluid that often limits breathing following coronavirus infection because “old folks don’t have a strong enough cough to clear it up,” Christman said.

Quitting can reduce inflammation

A second short-term gain from quitting smoking comes from reducing ongoing inflammation in your body, which can predispose you to Covid-19.
“If you quit smoking, the chronic inflammation goes away after a few weeks,” Christman said.
You’ll notice you won’t have as many symptoms of being short of breath when walking or climbing stairs, the CDC says.
Christman noted that smokers tend to need several months to stop producing higher levels of mucus, which their lungs create in order to clear out tar and other particulates contained in cigarettes.
“In terms of structural change, it takes a little while to clear the whole space,” he said.
Having your lungs in as good of shape as you can in case of a coronavirus infection is key. Covid-19 patients frequently experience acute lung injury, which can cause leakiness in mucus membranes, leading to what’s called acute respiratory distress syndrome, Christman said. This condition can result in patients drowning in their own mucus.
For smokers, “at baseline you’re set up for chronic bronchitis,” Christman said. “With Covid, it gets worse.”
And even if you’re not living in an area where there are numerous coronavirus cases, your decision to quit smoking might pay off down the road. That’s because public health authorities have projected multiple waves of cases over the next 18 months could be possible.
“It’s an investment in the future,” he said. “Covid might circulate in the Southern Hemisphere and then come back. Someone quitting now might really help themselves in the second wave.”

Respiratory failure is a common cause of death

For those who are diagnosed with Covid-19 and either fall seriously ill or die from it, respiratory failure or significant lung damage is common.
According to the CDC’s Morbidity and Mortality Weekly Report through March 28, 78% of US Covid-19 cases requiring intensive care unit admission came from patients who self-reported a recognized risk factor or a diagnosis of at least one underlying medical condition.
Current or former smoking status was among the shortlist of risk factors, along with other traits known to put people at risk for respiratory illness, including pregnancy. The most commonly reported underlying conditions included diabetes, chronic lung disease, cardiovascular disease, and immune compromised conditions.

Quitting smoking helps with blood circulation

Besides lung-related issues, smoking cessation can also deliver healthy benefits to the heart that could help stave off the possibility of cardiac arrest. Heart attacks are another cause of death in Covid-19 cases.
After you quit smoking, your blood becomes thinner and less susceptible to clotting, the CDC says. Heart attacks are less likely. One reason this happens is because smokers inhale carbon monoxide, and thereby diminish their capacity to carry oxygen and make it harder for the heart to distribute blood throughout the body.
“There is the occasional patient with Covid who dies from heart failure,” Christman says. He noted that in some cases, clinicians were seeing patients with elevated levels of troponins — a sign of heart attack that can be triggered by a severe infection.
You may already be practicing social distancing, washing your hands frequently and avoiding touching your face. In addition to all these, limiting or quitting smoking is yet another important aspect of your anti-coronavirus arsenal.
“Now is the time to take care of yourself,” Christman said.

Bloomberg News: FTC Sues to Unwind Altria’s $12.8 Billion Juul Investment

*April 6 Update* The Federal Trade Commission posted the complaint on their website. You can read the complaint by clicking here.

 

This article appeared on Bloomberg’s Business News webpage on April 2. The original link to the story can be found here

FTC Sues to Unwind Altria’s $12.8 Billion Juul Investment

By: and 

U.S. antitrust officials sued to reverse Altria Group Inc.’s troubled $12.8 billion deal to take a stake in vaping company Juul Labs Inc., saying the companies are competitors who shouldn’t be in business together.

The move further chips away at a much-heralded late 2018 deal that was supposed to combine the marketing might of Marlboro maker Altria with the savvy cool of Silicon Valley startup Juul. Instead, Altria has written down the investment twice, slashing the 35% stake’s value to $4.2 billion in January as health concerns about e-cigarettes led to a regulatory crackdown. Nonetheless, Altria vowed Wednesday to defend the deal.

The Federal Trade Commission’s complaint argues that Altria and Juul were aggressive rivals until Altria decided to end the competition by shutting down its own e-cigarette brands, MarkTen and Green Smoke, before acquiring its stake in Juul.

“Altria and Juul turned from competitors to collaborators by eliminating competition and sharing in Juul’s profits,” Ian Conner, director of the FTC’s Bureau of Competition, said in a statement

The complaint is the latest hurdle for the deal, which gave the largest U.S. cigarette maker a piece of the nation’s largest e-cigarette maker and was criticized from the start. Altria investors bemoaned the price tag and longtime Juul employees said the transaction flew in the face of Juul’s stated mission to rid the world of cigarettes.

The FTC’s challenge could cost Altria its piece of the e-cigarette market, which had appeared to be an avenue for growth as smoking rates decline and the market for tobacco shrinks. At the same time, it could release the company from the troubled investment. Complicating the process for Altria is the fact that Chief Executive Officer Howard Willard has contracted Covid-19 and has taken a medical leave of absence.

Altria shares gained 0.9% to $37.95 in premarket trading Thursday. Through the close of trading Wednesday, the stock had fallen 25% this year, roughly in line with the drop in the broader market caused by the coronavirus crisis.

“We believe that our investment in Juul does not harm competition and that the FTC misunderstood the facts,” Altria General Counsel Murray Garnick said in a statement. Juul declined to comment.

For Juul, it poses yet another hurdle for the embattled company to overcome as it grapples with investigations of its business practices that allegedly helped spark a surge of underage vaping. The company is now a target of federal investigations and lawsuits from parents and school districts. The FTC also has a separate probe into the company’s marketing.

Juul and other e-cigarette makers must soon submit applications to the Food and Drug Administration to continue selling their products in the U.S.

It’s unclear how the investment could be unwound. Juul has spent the bulk of the $12.8 billion to pay out investors and award bonuses to its employees. Other Juul investors include Fidelity Investments and Tiger Global Management. Altria was supposed to gain voting rights and board seats at Juul with antitrust clearance.

Unanimous Vote

The FTC’s five commissioners voted unanimously to file a complaint in its administrative court and a trial has been scheduled to begin on Jan. 5, 2021. The complaint threatens to tie up Altria in litigation for months. The cases are heard by an administrative law judge and then by the full five-member commission. Decisions can be appealed to federal court.

The complaint, which hasn’t been made public, follows a year-long investigation by the FTC into whether Altria’s investment violated antitrust laws.

In October 2018, Altria pulled its pod-based e-cigarette products from the market and sent a letter to Scott Gottlieb, then the commissioner of the Food and Drug Administration, blaming products like Juul’s for fueling a teen vaping epidemic. Two months later, Altria closed its e-cigarette business entirely and then announced its Juul investment.

As part of the deal, Altria gave Juul some of its shelf space and promised its help with an upcoming regulatory application that will determine whether Juul can continue to sell its e-cigarettes in the U.S. In the fall of 2019, a longtime Altria executive who pursued the investment, K.C. Crosthwaite, took over as Juul’s CEO and hired Altria colleague Joe Murillo as Juul’s chief regulatory officer.

Health Scare

Juul, once among the most valuable start-ups in the U.S., saw its fortunes quickly diminish last year. A health scare that was later tied to faulty cannabis vaping products spooked consumers and prompted governors and state regulators to crack down.

The company laid off about 650 people last fall and implemented a $1 billion restructuring plan. A number of executives have left amid the shake up. Co-founder James Monsees and Chief Transformation Officer Guy Cartwright both left within the past month.

Altria has been “highly disappointed” in the investment, CEO Willard said in January. Lawsuits accusing Juul of hooking minors to nicotine have ballooned, including many that name Altria as a co-defendant. The company has since narrowed the terms of its cooperation with Juul away from marketing and solely to gaining regulatory approval.

FTC Scrutiny

The FTC is increasingly questioning deals where upstart competitors are swallowed up by established players. In February, the agency demanded new information about startup acquisitions by Alphabet Inc., Apple Inc., Amazon.com Inc., Facebook Inc. and Microsoft Corp. that had previously flown under its radar to determine whether they should have been blocked. The same month, the FTC sued to block the merger of Edgewell Personal Care Co., the maker of Schick razors, with Harry’s, the shaving-supply company.

The U.S. Securities and Exchange Commission is investigating the Altria-Juul deal, according to a report last month from the Wall Street Journal.

(Updates stock-price information in seventh paragraph. A previous version of this article corrected the date that Altria closed down its e-cigarette business in 14th paragraph.)

Post Bulletin: I’m a smoker … And along comes a pandemic

This article appeared online for the Post Bulletin out of Minnesota. It was published on March 31. The original article can be read by clicking here.

 

I’m a smoker … And along comes a pandemic

Matthew Stolle mstolle@postbulletin.com

Mar 31, 2020 Updated Apr 1, 2020

It’s never been a great time to be a smoker. Now in the midst of a pandemic, it just got riskier for smokers.

Yet smoking is a coping mechanism for many, and pandemics are nothing if not stressful.

Dr. J. Taylor Hays, director of the Mayo Clinic Nicotine Dependence Center, talked with the PB about the heightened risks smokers face and why now might be the time to quit.

PB: Why are smokers at risk for COVID-19?

Hays: Several things are at play. One of the more obvious ones is that smokers have a higher risk for all kinds of conditions that are associated with more risk of complications from COVID-19. So, for example, chronic lung disease, COPD, emphysema. People with chronic lung disease have a higher risk of complications and more serious and critical infections.

More specifically, we know that smoking decreases the ability of the lungs to fight infection. The main thing that smoking does is impede the clearance of mucus from the lungs. We have in our lungs little hairs on the cells called cilia that beat in a coordinated fashion and move the mucus we produce up (towards the throat). That’s how we clear infections.

In smokers, those cilia don’t work. They’re paralyzed.

PB: So if I’m a smoker, I’m more susceptible to COVID-19. And if I get the infection, my symptoms are more likely to be more severe. Is that right?

Hays: More complicated, more severe, longer recovery time. Greater chance of having to go to the hospital, developing lower respiratory infections and pneumonia.

Early data from China suggests that smokers were over-represented among the people who had severe and critical illness, who had higher risk of mortality from the COVID infection.

PB: Here’s a hard-hearted question: Smokers know the risks. Why should I care?

Hays: You’re right. People do make choices in their lives. And some of those choices end up costing them. And in this case, the cost could be dear. But my comeback to that is: Because of the nicotine in tobacco causes addiction, people really lose the ability to choose.

So if a chemical is driving the urge to smoke and causing withdrawal around quitting, those are hallmarks of addiction.

Also, smoking doesn’t just impact you. It impacts people around you. If you’re inside your house, which we all are, and you’re smoking, second-hand smoke exposure is also a risk factor for more serious COVID 19 infection.

PB: Let’s say the pandemic scares me enough to consider stop smoking. If I stopped now, would I get any appreciable benefits?

Hays: The answer to that is an unequivocal yes. We know that within hours of stopping, respiratory symptoms begin to improve. Within days, the clearance of mucus begins to improve.

PB: What is the percentage of people who smoke?

Hays: It’s gotten a lot better in the U.S. We’re now down for all adults to 15 percent to 17 percent in most states. In Minnesota, we’re probably down to 14 percent. That’s the lowest we’ve been since before World War II.

PB: Do the risks you describe also apply to marijuana smokers and people who vape?

Hays: The answer to that is unknown. We presume that if you inhale any combustible product or e-cigarettes, that it can cause some irritation to the lung. That’s probably not a good thing to do. If you’re exposed to COVID and have to fight an infection, we presume it would increase your risk. But there’s no data on that yet.

Those interested in quitting can find more information by calling 1-800-quit-now, a national quit line. You can also access information at becomeanex.org.

 

Forbes: Smokers At Higher Risk Of Severe COVID-19 During Coronavirus Outbreak

This article from Forbes.com was posted on March 23. Link to the article found here

Victoria Forster

Contributor; Healthcare
Cancer research scientist and childhood cancer survivor.

A leading expert has warned that smokers are likely at increased risk of more severe COVID-19, compared to non-smokers, suggesting that now would be a particularly good time to try and quit or cut down.

“There’s not very much data at this point on COVID-19 in smokers, but we do know from reports from China, smokers seem to be over-represented in groups of people who have severe or critical COVID-19,” said J. Taylor Hays, M.D. Director of the Nicotine Dependence center at Mayo Clinic in Rochester, Minnesota and Professor of Medicine, Mayo Clinic College of Medicine.

Increasing evidence is suggesting that smokers are at higher risk of severe COVID-19 than those who don’t smoke. One study published in the New England Journal of Medicine in February looked at 1,099 patients in China with COVID-19, showing that of 173 patients who had severe symptoms, 16.9% of them were current smokers and 5.2% had previously smoked. Among the patients with less-severe symptoms, 11.8% were current smokers and 1.3% former smokers.

More worryingly, the study showed that in a group of patients that either needed mechanical ventilation, admission to an intensive care unit, or ultimately died, 25.5% were current smokers, which was more than twice the rate of current smokers in a group of patients that did not have these severe adverse outcomes.

“These observations about more severe illness in smokers vs people who have never smoked seems to parallel what is seen in respiratory viruses such as respiratory syncytial virus and seasonal influenza, where smokers tend to do worse than non-smokers,” said Hays, also mentioning that no data is currently available on people who vape or use e-cigarettes. “We know that inhalation of combustible tobacco of any sort seems to be associated with more severe disease from respiratory viruses,” he added.

Studying other coronavirus outbreaks provides further suggestions that smokers may fare worse with these types of viral infections than non-smokers. In a study of a small number of patients with Middle-East Respiratory Syndrome (MERS) in South Korea, patients who smoked were less likely to survive than those who did not. There was also some evidence that smokers had higher levels of a protein called DPP4, a receptor which allows the MERS coronavirus to enter cells in the lung, which could make their lung cells more susceptible to attack from the virus. SARS-CoV2, the coronavirus responsible for the current outbreak, uses a different receptor to gain access to lung cells called ACE2. However, the news here isn’t any better for smokers either.

“The ACE2 receptor is up-regulated in the respiratory cells of smokers. This might be a mechanism by which it is more likely to cause severe illness,” said Hays.

There are also other, well-proven reasons for smokers to be concerned about their risk of severe or fatal COVID-19.

“There is a long history of smokers having more severe respiratory illness in general and this is for a few well-established reasons. They clear mucus less efficiently, the cilia which get infectious particles and secretions out of the lungs, work less efficiently. Smoking also causes inflammation in the airways, which is made worse with respiratory illnesses,” said Hays.

So if you are reading this and you smoke or know someone who does, is it too late now to stop or cut down?

“People who quit for even a short time see an improvement in lung health quite quickly. For most smokers who don’t already have serious lung injury, they will see immediate improvements in their health, and less opportunity for severe diseases including COVID-19,” said Hays.

In 2015, the CDC reported that almost 7 out of 10 adult smokers wanted to try and quit, with over half of all of them trying to quit at least once in that year, but the large majority not succeeding. Is it likely that people will try to quit, and succeed, especially at such a stressful time for many?

“I understand people turn to things because it’s a coping mechanism, especially at stressful times. I would say to them – try and flex other coping muscles, there is a real opportunity to break routines – even a short period of abstinence from smoking improves lung function,” said Hays.

“People could look at this as an opportunity – a time of crisis is a time of opportunity. If you’ve been looking for an opportunity to quit, this is it,” he added.

Could Your E-Cig Disrupt Your Pacemaker?

March 16, 2020, at 9:00 a.m.

U.S. News & World Report

By Rich Holmes
HealthDay Reporter

(HEALTHDAY)

MONDAY, March 16, 2020 (HealthDay News) — The magnets in vaping devices might be able to wreak havoc on heart pacemakers and defibrillators, a new case report suggests.

By placing a Juul in his shirt pocket, a heart patient caused his implanted pacemaker and defibrillator to malfunction, his health care providers said.

“To our knowledge, this is the first time it’s been reported,” said report author Julie Shea, nurse practitioner at the Cardiovascular Arrhythmia Service at Brigham and Women’s Hospital in Boston.

The 48-year-old male patient had a history of irregular heartbeats, or arrhythmia. A magnet in the e-cigarette kept his implanted cardioverter-defibrillator (ICD) from detecting and correcting episodes of arrhythmia, Shea said.

Fortunately, the man experienced no deadly episodes of arrhythmia before the problem was discovered and resolved, his doctors said.

Heart patients are warned to keep devices or objects that contain magnets or create a magnetic field away from their implanted pacemakers and defibrillators, Shea said. These include power tools, bank cards and name tags with magnetic strips, and cellphones. “Never store them in a shirt or jacket pocket,” she said.

But a warning about vaping devices has not been made until now, Shea said.

The U.S. Food and Drug Administration says research doesn’t indicate cellphones pose a significant risk to pacemaker operation, but recommends not storing it in a pocket directly over the pacemaker. The American Heart Association gives similar advice, suggesting cellphones and devices containing magnets be kept 6 inches away from pacemakers and defibrillators.

Shea and co-author Dr. Usha Tedrow, director of the Clinical Cardiac Electrophysiology Program at the Cardiovascular Arrhythmia Service at Brigham and Women’s, were first tipped off to the problem when the patient told them his combination pacemaker/ICD had emitted a warning tone several times. However, remote monitoring showed his heart device was working normally. He also complained of no ill symptoms and said he hadn’t had any magnetic devices near his chest.

But when they checked with the devices’ manufacturer for further information, data showed magnetic interaction had occurred at four times when the man had heard the tone.

“I actually saw that device” when the patient visited the office, Shea said. “I asked him, ‘What is that in your pocket?'”

The man then said the Juul had been in his chest pocket when his cardiac device had sounded the tone.

The findings were published March 16 in the journal HeartRhythm Case Reports.

The case study is a warning, Shea said, but the authors cannot extend it to all brands and models of vaping devices, as they only studied the Juul.

“Our intent is educational for providers and patients,” she noted. “We want our colleagues to be aware.”

Tedrow said heart patients who use Juuls could continue to use them “with adequate education.”

According to Juul Labs’ website, a Juul uses magnets to secure it to its USB charging dock. The company suggests keeping Juuls away from items with magnetic strips, such as credit cards, and cautions that the magnets may trigger a laptop to switch into sleep mode when using a computer’s USB port to charge. The website also says its products meet international safety standards for electromagnetic compatibility. The company did not respond to requests for comment.

Dr. Dhanunjaya Lakkireddy, executive medical director of electrophysiology at the Kansas City Heart Rhythm Institute, said e-cigarettes should not be kept in chest pockets. He said older pacemakers and combination pacemaker/ICDs would be more vulnerable to magnets in vaping devices, as newer models are now shielded.

Still, Lakkireddy, who wasn’t part of the study, cautioned that if a Juul’s magnets can cause a laptop to go into sleep mode, they might well cause a pacemaker/ICD to malfunction.

“The FDA needs to go back and look at these,” said Lakkireddy.

More information

To learn more about keeping pacemakers and ICDs safe from magnetic fields, go to the American Heart Association.

Copyright © 2020 HealthDay. All rights reserved.

Tobacco Free North Dakota announces its first annual Video Essay Scholarship Contest for all ND High School Seniors.

Tobacco Free North Dakota announces its first annual Video Essay Scholarship Contest for all ND High School seniors. TFND is a statewide non-profit that advocates for policies to prevent youth initiation to tobacco and nicotine products with the goal of creating North Dakota’s first tobacco free generation. We hope this scholarship contest encourages youth to youth education and advocacy, while providing TFND an opportunity to recognize and reward those efforts.
Tobacco Free ND Video Essay Scholarship Contest
Here’s how it works!
1. Create a 1–3 minute YouTube video based on one of these Tobacco Free ND topics.
• The True Cost of Tobacco/Nicotine
• How Does Tobacco/Nicotine Affect Me/How Would Tobacco Affect Me?
• Why I stay Tobacco/Nicotine Free!
2. Email your YouTube video entry by April 15, 2018 to heather@tfnd.org. A committee will select the top five videos, which will then be displayed at www.tfnd.org and voted on by the public May 1-11, 2018. (Tell your friends to vote!) The winner will be announced May 18, 2018.
3. The winner will receive a $1,000 college scholarship! TFND will present the prize and take photos with the winner prior to the end of the school year.
 
Requirements/Guidelines:
• Must be a ND high school senior who will be attending college in fall 2018.
• Create a short 1–3 minute YouTube video relating to Tobacco. (Please introduce yourself in the video)
• The Tobacco Free North Dakota Board and/or judging committee has the right to disqualify videos deemed unacceptable or inappropriate.
• Deadline for submission: April 15, 2018.
• Video participants agree and authorize TFND, or anyone authorized by TFND, the use of any and all images that have been taken of the participant and/or friends/family without compensation to the participant. Participants agree that the TFND may use such videos with or without the participant’s name for any lawful purpose, including purposes of publicity, illustration, advertising and web content.
• Emailing your submission acts as your signature to agreement to the terms and conditions of this contest.
• The winning video becomes the property of TFND. In order to receive the scholarship, the winner will submit the video file.
 
Send all Questions and Entries by April 15, 2018 to: Heather Austin, heather@tfnd.org
The mission of Tobacco Free North Dakota is to improve and protect the public health of all North Dakotans by reducing the serious health and economic consequences of tobacco use, the state’s number one cause of preventable disease and death.

Letter: Keep tobacco firms away from kids

by Stephen McDonough, published Apr 23, 2017 in the Bismarck Tribune
The fight to protect our kids from tobacco is facing new threats both here in North Dakota and in Congress.
Our state lawmakers voted to eliminate BreatheND — also known as the North Dakota Center for Tobacco Prevention and Control Policy — which has helped cut youth cigarette smoking in half since its creation in 2008.
In Congress, tobacco companies are pushing legislation that would greatly weaken Food and Drug Administration rules to protect kids from electronic cigarettes and cigars — products that threaten to hook a new generation and undermine the enormous progress we’ve made. Tobacco companies have introduced a huge assortment of candy-flavored e-cigarettes and cigars, making them wildly popular with kids.
To keep making progress against tobacco, our federal lawmakers must ensure the FDA has the tools it needs to protect the nation’s kids.
Last year, the FDA took an important step by issuing new rules for cigars and e-cigarettes — including a nationwide ban on sales to minors. However, instead of supporting these efforts, Congress is considering two measures that would dramatically weaken FDA oversight of these products.
The first bill would make it far more difficult for the FDA to protect kids from e-cigarettes and cigars already on the market, including the many candy-flavored products introduced in recent years. The second would completely exempt “large and premium” cigars from FDA oversight — a category defined so broadly that it could be stretched to apply to low-cost, flavored cigars. Tobacco companies are working to include these proposals in a spending bill Congress must pass this month to keep the federal government running.
Sen. John Hoeven, R-N.D., who chairs the Senate Appropriations subcommittee that oversees FDA funding, should make certain that neither of these harmful proposals become law. Especially at a time when North Dakota has just lost the agency that helps prevent tobacco use, Hoeven and our other federal lawmakers must protect North Dakota’s kids and not weaken the FDA’s authority over e-cigarettes and cigars.
These proposals don’t make any sense considering the lure of these products to kids.
Today there are more than 7,700 different flavors of e-cigarettes and about 250 different flavors of cigars, with choices like gummy bear, peanut butter cup and cotton candy for e-cigarettes and lemonade, cherry dynamite and wild berry for cigars. Kids admit these flavors are appealing. Among current youth e-cigarette users, more than 80 percent say they are drawn by the available flavors, according to a government study. Nearly 75 percent of youth cigar smokers say the same thing.
It’s no surprise, then, that so many kids are using these products. Nationwide, use of e-cigarettes among high schoolers grew by a factor of 10 between 2011 and 2015, climbing to 16 percent, according to the National Youth Tobacco Survey. Here in North Dakota, the problem is even worse: 22 percent of high school students use e-cigarettes compared to 12 percent who smoke regular cigarettes.
In addition, more high school boys in North Dakota now smoke cigars than cigarettes —13.2 percent compared to 11.9 percent for traditional cigarettes.
According to a 2016 report by the surgeon general, the nicotine in e-cigarettes is highly addictive and “can harm the developing adolescent brain.” The surgeon general also concluded, “E-cigarette use is strongly associated with the use of other tobacco products among youth and young adults, including combustible tobacco products.”
Cigar smoke, meanwhile, contains the same harmful chemicals found in cigarette smoke, and has been shown to cause cancer of the lungs, esophagus, larynx and oral cavity.
By weakening FDA oversight of tobacco products that attract kids, the proposals before Congress pose a serious threat to the health and well-being of America’s youth. Hoeven should do all he can to stop them from being enacted into law.
Stephen McDonough is a Bismarck pediatrician.

Letter: Listen to Voters on Tobacco-Prevention Funding

Letter: Listen to voters on tobacco-prevention funding
By Sarah Odegard on Jan 5, 2017 Grand Forks Herald
When I cast my vote for North Dakota’s legislators, I expect they’ll bring my interests and values to the Capitol. But now that BreatheND’s funding is in under attack, I think maybe our legislators need a reminder about what the people want.
Here’s a hint: we want BreatheND!
I voted for Measure 3 seven years ago. This was the measure that dedicated a portion of the tobacco settlement dollars to support tobacco prevention and created BreatheND.
I voted for it because as a nurse, I’ve seen first-hand how tobacco ruins lives. The measure passed because the majority of North Dakotans believe tobacco prevention education saves lives and health care costs. As it turned out, we were right.
BreatheND has greatly reduced the number of young people and adults in North Dakota who use tobacco. Tobacco use still costs North Dakota $326 million a year in health care costs and $56.9 million a year in Medicaid costs. The work isn’t done yet, but think of how much we’ve saved by cutting youth smoking rates in half.
Voters get it. We have built momentum to make even more significant impacts on tobacco rates and save even more money on health care and insurance.
The 2015 North Dakota Public Opinion Survey says 90 percent of North Dakotans support continuing BreatheND. We stand by our vote, and legislators can’t ignore those numbers.
Now, we need our legislators to stand by us.
As representatives of our state, legislators must hear what the people want and follow through accordingly.
Hear us now.
Support Senate Bill 2024 to fully fund BreatheND and continue this important work.
Sarah Odegard
Reynolds, N.D.